Bone mineral density in postmenopausal breast cancer survivors.

Janice J Twiss, Nancy Lauraine Waltman, C. D. Ott, G. J. Gross, A. M. Lindsey, Timothy Eisdell Moore

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

PURPOSE: The overall purpose of this longitudinal 18-month study was to test the feasibility and effectiveness of a multicomponent intervention for prevention and treatment of osteoporosis. The purpose of this article is to describe the baseline bone mineral density (BMD) findings for 30 postmenopausal women and to compare these BMD findings to time since menopause, body mass index, and tamoxifen use. DATA SOURCES: Baseline data of BMD findings for 30 postmenopausal women, who have had a variety of treatments including surgery, adjuvant chemotherapy and or tamoxifen, and are enrolled in the 18-month longitudinal study. A demographic questionnaire and a three day dietary record were used to collect baseline data. CONCLUSIONS: Eighty percent of the women with breast cancer history had abnormal BMDs at baseline (t-scores below -1.00 SD). Thinner women showed a greater risk for accelerated trabecular bone loss at the spine and hip. IMPLICATIONS FOR PRACTICE: These findings suggest the need for early BMD assessments and for aggressive health promotion intervention strategies that include a multifaceted protocol of drug therapy for bone remodeling, 1500 mg of daily calcium, 400 IU vitamin D and a strength weight training program that is implemented immediately following chemotherapy treatment and menopause in this high risk population of women.

Original languageEnglish (US)
Pages (from-to)276-284
Number of pages9
JournalJournal of the American Academy of Nurse Practitioners
Volume13
Issue number6
StatePublished - Jan 1 2001

Fingerprint

Bone Density
Survivors
Breast Neoplasms
Tamoxifen
Menopause
Diet Records
Drug Therapy
Resistance Training
Bone Remodeling
Adjuvant Chemotherapy
Health Promotion
Vitamin D
Osteoporosis
Longitudinal Studies
Hip
Spine
Body Mass Index
Therapeutics
Demography
Calcium

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Bone mineral density in postmenopausal breast cancer survivors. / Twiss, Janice J; Waltman, Nancy Lauraine; Ott, C. D.; Gross, G. J.; Lindsey, A. M.; Moore, Timothy Eisdell.

In: Journal of the American Academy of Nurse Practitioners, Vol. 13, No. 6, 01.01.2001, p. 276-284.

Research output: Contribution to journalArticle

@article{976b1f8aadf9467f982f5cb5b9103c3d,
title = "Bone mineral density in postmenopausal breast cancer survivors.",
abstract = "PURPOSE: The overall purpose of this longitudinal 18-month study was to test the feasibility and effectiveness of a multicomponent intervention for prevention and treatment of osteoporosis. The purpose of this article is to describe the baseline bone mineral density (BMD) findings for 30 postmenopausal women and to compare these BMD findings to time since menopause, body mass index, and tamoxifen use. DATA SOURCES: Baseline data of BMD findings for 30 postmenopausal women, who have had a variety of treatments including surgery, adjuvant chemotherapy and or tamoxifen, and are enrolled in the 18-month longitudinal study. A demographic questionnaire and a three day dietary record were used to collect baseline data. CONCLUSIONS: Eighty percent of the women with breast cancer history had abnormal BMDs at baseline (t-scores below -1.00 SD). Thinner women showed a greater risk for accelerated trabecular bone loss at the spine and hip. IMPLICATIONS FOR PRACTICE: These findings suggest the need for early BMD assessments and for aggressive health promotion intervention strategies that include a multifaceted protocol of drug therapy for bone remodeling, 1500 mg of daily calcium, 400 IU vitamin D and a strength weight training program that is implemented immediately following chemotherapy treatment and menopause in this high risk population of women.",
author = "Twiss, {Janice J} and Waltman, {Nancy Lauraine} and Ott, {C. D.} and Gross, {G. J.} and Lindsey, {A. M.} and Moore, {Timothy Eisdell}",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
volume = "13",
pages = "276--284",
journal = "Journal of the American Academy of Nurse Practitioners",
issn = "1041-2972",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Bone mineral density in postmenopausal breast cancer survivors.

AU - Twiss, Janice J

AU - Waltman, Nancy Lauraine

AU - Ott, C. D.

AU - Gross, G. J.

AU - Lindsey, A. M.

AU - Moore, Timothy Eisdell

PY - 2001/1/1

Y1 - 2001/1/1

N2 - PURPOSE: The overall purpose of this longitudinal 18-month study was to test the feasibility and effectiveness of a multicomponent intervention for prevention and treatment of osteoporosis. The purpose of this article is to describe the baseline bone mineral density (BMD) findings for 30 postmenopausal women and to compare these BMD findings to time since menopause, body mass index, and tamoxifen use. DATA SOURCES: Baseline data of BMD findings for 30 postmenopausal women, who have had a variety of treatments including surgery, adjuvant chemotherapy and or tamoxifen, and are enrolled in the 18-month longitudinal study. A demographic questionnaire and a three day dietary record were used to collect baseline data. CONCLUSIONS: Eighty percent of the women with breast cancer history had abnormal BMDs at baseline (t-scores below -1.00 SD). Thinner women showed a greater risk for accelerated trabecular bone loss at the spine and hip. IMPLICATIONS FOR PRACTICE: These findings suggest the need for early BMD assessments and for aggressive health promotion intervention strategies that include a multifaceted protocol of drug therapy for bone remodeling, 1500 mg of daily calcium, 400 IU vitamin D and a strength weight training program that is implemented immediately following chemotherapy treatment and menopause in this high risk population of women.

AB - PURPOSE: The overall purpose of this longitudinal 18-month study was to test the feasibility and effectiveness of a multicomponent intervention for prevention and treatment of osteoporosis. The purpose of this article is to describe the baseline bone mineral density (BMD) findings for 30 postmenopausal women and to compare these BMD findings to time since menopause, body mass index, and tamoxifen use. DATA SOURCES: Baseline data of BMD findings for 30 postmenopausal women, who have had a variety of treatments including surgery, adjuvant chemotherapy and or tamoxifen, and are enrolled in the 18-month longitudinal study. A demographic questionnaire and a three day dietary record were used to collect baseline data. CONCLUSIONS: Eighty percent of the women with breast cancer history had abnormal BMDs at baseline (t-scores below -1.00 SD). Thinner women showed a greater risk for accelerated trabecular bone loss at the spine and hip. IMPLICATIONS FOR PRACTICE: These findings suggest the need for early BMD assessments and for aggressive health promotion intervention strategies that include a multifaceted protocol of drug therapy for bone remodeling, 1500 mg of daily calcium, 400 IU vitamin D and a strength weight training program that is implemented immediately following chemotherapy treatment and menopause in this high risk population of women.

UR - http://www.scopus.com/inward/record.url?scp=0035382834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035382834&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 276

EP - 284

JO - Journal of the American Academy of Nurse Practitioners

JF - Journal of the American Academy of Nurse Practitioners

SN - 1041-2972

IS - 6

ER -